Company record
A clear public starting point.
This page gathers the company’s published description, taxonomy, status, and official link in one place. It does not make claims about private activity or deal terms.
Startup in Sahin’s portfolio
Latus Bio: company profile
Latus Bio is developing curative AAV gene therapy products for CNS disorders
Key Investors
Why I Invested
As an angel investor in 234 startups across 14 categories, I look for companies with exceptional founders, large addressable markets, and clear competitive advantages. Latus Bio stood out in the Biotech space.